PhaseBio Pharmaceuticals, Inc. ( PHAS) - Price History
Stock symbol PHAS is outdated, potentially delisted? Maybe it is available on other exchange?
Monthly price history for PHAS (PhaseBio Pharmaceuticals, Inc.)
| Date | Adjusted price | Real price |
|---|---|---|
| June 2026 | $0.07 | $0.07 |
| May 2023 | $0.07 | $0.07 |
| April 2023 | $0.07 | $0.07 |
| March 2023 | $0.07 | $0.07 |
| February 2023 | $0.07 | $0.07 |
| January 2023 | $0.07 | $0.07 |
| December 2022 | $0.03 | $0.03 |
| November 2022 | $0.05 | $0.05 |
| October 2022 | $0.10 | $0.10 |
| September 2022 | $0.18 | $0.18 |
| August 2022 | $1.06 | $1.06 |
| July 2022 | $1.12 | $1.12 |
| June 2022 | $0.60 | $0.60 |
| May 2022 | $0.77 | $0.77 |
| April 2022 | $1.21 | $1.21 |
| March 2022 | $1.32 | $1.32 |
| February 2022 | $1.13 | $1.13 |
| January 2022 | $2 | $2 |
| December 2021 | $2.61 | $2.61 |
| November 2021 | $2.08 | $2.08 |
| October 2021 | $3.76 | $3.76 |
| September 2021 | $3.11 | $3.11 |
| August 2021 | $3.24 | $3.24 |
| July 2021 | $3.51 | $3.51 |
| June 2021 | $3.72 | $3.72 |
| May 2021 | $3.38 | $3.38 |
| April 2021 | $3.03 | $3.03 |
| March 2021 | $3.46 | $3.46 |
| February 2021 | $3.88 | $3.88 |
| January 2021 | $3.85 | $3.85 |
| December 2020 | $3.36 | $3.36 |
| November 2020 | $3.80 | $3.80 |
| October 2020 | $2.73 | $2.73 |
| September 2020 | $3.51 | $3.51 |
| August 2020 | $3.86 | $3.86 |
| July 2020 | $4 | $4 |
| June 2020 | $4.60 | $4.60 |
| May 2020 | $6.01 | $6.01 |
| April 2020 | $3.86 | $3.86 |
| March 2020 | $3.31 | $3.31 |
| February 2020 | $4.21 | $4.21 |
| January 2020 | $4.98 | $4.98 |
| December 2019 | $6.11 | $6.11 |
| November 2019 | $3.26 | $3.26 |
| October 2019 | $4.11 | $4.11 |
| September 2019 | $4.17 | $4.17 |
| August 2019 | $8.64 | $8.64 |
| July 2019 | $7.81 | $7.81 |
| June 2019 | $13.12 | $13.12 |
| May 2019 | $10.68 | $10.68 |
| April 2019 | $13.10 | $13.10 |
| March 2019 | $9.51 | $9.51 |
| February 2019 | $3.16 | $3.16 |
| January 2019 | $3.30 | $3.30 |
| December 2018 | $3.09 | $3.09 |
| November 2018 | $2.85 | $2.85 |
| October 2018 | $5.10 | $5.10 |
PHAS
Price: $0.07
52 week price:
Earnings Per Share: -2.64 USD
P/E Ratio: -1.33
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 8.6 million
Market Capitalization: 3.4 million